Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Africa secures 400 million more COVID-19 vaccine doses

Thu, 28th Jan 2021 12:27

* African Union secures 400 mln more AstraZeneca doses

* Health bodies hope to cover 60% of Africans in 2-3 years

* Tanzania's president says God and steam will protect
people
(Recasts, with details about vaccines)

By George Obulutsa

NAIROBI, Jan 28 (Reuters) - The African Union (AU) has
secured another 400 million doses of the AstraZeneca
COVID-19 vaccine, a regional health leader said on Thursday, in
a push to immunize 60% of the continent's population over three
years.

As richer nations race ahead with mass immunisation
campaigns, Africa is scrambling to obtain supplies for its 1.3
billion people. Only a handful of African nations have begun
giving doses.

John Nkengasong, director of the AU's disease control and
prevention body, told an online briefing that in addition to 270
million doses previously secured, the bloc would get 400 million
shots from the Serum Institute of India (SII) - all
AstraZeneca/Oxford University shots.

A spokesman for the SII declined comment.

The AstraZeneca vaccine is the cheapest option and one of
the best-suited to African health systems as it does not require
storage at ultra-low temperatures like the vaccine from Pfizer
and German partner BioNTech.

Separately from the AU's efforts, Africa is to receive about
600 million vaccine doses this year via the COVAX facility
co-led by the World Health Organization (WHO).

Health authorities hope to vaccinate about 30-35% of
Africans this year, rising to 60% in two to three years. The AU
has said vaccines secured by its vaccine task team will be
allocated according to population.

Though COVID-19 has not hit Africa as badly as some experts
had feared it would, wealth disparities, logistical difficulties
and "vaccine nationalism" by developed nations may put the
world's poorest continent at a disadvantage.

Africa has reported 3.5 million infections and 88,000
deaths, according to a Reuters tally. That is fewer fatalities
than individual nations the United States, Brazil, India, Mexico
and Britain.

OUTLIER TANZANIA

In an implicit rebuke to Tanzanian President John Magufuli,
who has discouraged mask-wearing and social distancing,
discontinued data publication and called vaccines a malign
foreign plot, WHO Africa director Matshidiso Moeti urged
Tanzania to implement such measures, prepare vaccinations and
share data.

"Africa is at a crossroads and all Africans must double down
on preventive measures," she told an online news conference on
Thursday, saying WHO officials were in touch with Tanzanian
officials. "Science shows that vaccines work."

Magufuli's government has published no coronavirus data
since May 8, when the country had 509 cases and 21 deaths.

On Wednesday, he said, without evidence, that vaccines were
a foreign plot to spread illness and steal Africa's wealth. He
urged Tanzanians instead to trust God and use alternative
remedies such as steam inhalation.

"We in Tanzania managed to stay for a year without corona.
Even here, no one has put on a mask. Our God is beyond Satan and
Satan will always fail using different diseases," he said in a
speech in his western home area.

Nkengasong said the Africa CDC was exploring obtaining more
vaccines from China, Russia and Cuba, and would work with any
partner whose vaccine was safe and effective.
(Reporting by George Obulutsa, Nairobi newsroom and Alexander
Winning;
Writing by Andrew Cawthorne
Editing by Alex Richardson and Frances Kerry)

More News
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.